{"component": "definition", "props": {"groups": [{"snippet": "means the process whereby the therapeutic effects and cost effectiveness of various drug therapies are reviewed, monitored and acted upon consistent with the Benefit Plan. DUR can be prospective, concurrent or retrospective.", "size": 8, "samples": [{"hash": "iq97Zb0GcJD", "uri": "/contracts/iq97Zb0GcJD#dur", "label": "Administrative Services Agreement", "score": 33.26197052, "published": true}, {"hash": "4CfjSVLa8ZU", "uri": "/contracts/4CfjSVLa8ZU#dur", "label": "Administrative Services Agreement", "score": 31.4735355377, "published": true}, {"hash": "lKCl8cDut66", "uri": "/contracts/lKCl8cDut66#dur", "label": "Administrative Services Agreement", "score": 24.7741279602, "published": true}], "snippet_links": [{"key": "the-process", "type": "clause", "offset": [6, 17]}, {"key": "cost-effectiveness", "type": "definition", "offset": [54, 72]}, {"key": "the-benefit-plan", "type": "clause", "offset": [154, 170]}], "hash": "291e68ec9335d9d78770876f76cf7b78", "id": 1}, {"snippet": "means the Department of Urban Roads in MRH;", "size": 6, "samples": [{"hash": "7NmaJuMzJfz", "uri": "/contracts/7NmaJuMzJfz#dur", "label": "Development Credit Agreement", "score": 21.0, "published": true}, {"hash": "4v9fWuSWFUK", "uri": "/contracts/4v9fWuSWFUK#dur", "label": "Development Credit Agreement", "score": 21.0, "published": true}], "snippet_links": [{"key": "department-of", "type": "clause", "offset": [10, 23]}], "hash": "8cdbdc42d78237595123634da9215039", "id": 2}, {"snippet": "means a clinical evaluation process within DPIN that evaluates a drug prescription against the patient\u2019s drug history and determines if there will be any adverse effect or precaution associated with the prescribed drug;", "size": 3, "samples": [{"hash": "kOjrhew0VHq", "uri": "/contracts/kOjrhew0VHq#dur", "label": "Pharmacy Agreement", "score": 32.5845413208, "published": true}, {"hash": "iLJjEJDoMF5", "uri": "/contracts/iLJjEJDoMF5#dur", "label": "Pharmacy Agreement", "score": 26.1704311371, "published": true}, {"hash": "eDMRWxB3dsv", "uri": "/contracts/eDMRWxB3dsv#dur", "label": "Pharmacy Agreement", "score": 24.6002731323, "published": true}], "snippet_links": [{"key": "evaluation-process", "type": "definition", "offset": [17, 35]}, {"key": "drug-history", "type": "definition", "offset": [105, 117]}, {"key": "adverse-effect", "type": "clause", "offset": [154, 168]}, {"key": "associated-with", "type": "definition", "offset": [183, 198]}, {"key": "prescribed-drug", "type": "definition", "offset": [203, 218]}], "hash": "a5e02b6fdc9cbc9d3a5e285d8bcb1eed", "id": 3}, {"snippet": "means Drug Utilization Review in which the system reviews each claim against all other claims from all sources in the system to determine if there is a detrimental interaction with another drug the member filled.", "size": 3, "samples": [{"hash": "9uadpw8Weg5", "uri": "https://www.nmrhca.org/wp-content/uploads/2021/10/IBAC_UNM-PBM-RFP-Final-with-all-appendices-for-posting-on-NMPSIA-website.pdf", "label": "www.nmrhca.org", "score": 10.8918552399, "published": false}, {"hash": "38dR12tlJdJ", "uri": "https://nmpsia.com/docs/IBAC_UNM_PBM_RFP-Final_with_all_appendices.pdf", "label": "nmpsia.com", "score": 10.8918552399, "published": false}, {"hash": "k9MHlLzRGsN", "uri": "https://nmrhca.sks.com/uploads/FileLinks/e100b9ebdfa24cb6b606d7c43b605756/2018_IBAC_0001_Pharmaceutical_Benefits_Managment_Services_IBAC_RFP_20170815_Final_1.pdf", "label": "nmrhca.sks.com", "score": 6.8097195625, "published": false}], "snippet_links": [{"key": "drug-utilization-review", "type": "definition", "offset": [6, 29]}, {"key": "the-system", "type": "definition", "offset": [39, 49]}, {"key": "each-claim", "type": "definition", "offset": [58, 68]}, {"key": "all-other-claims", "type": "clause", "offset": [77, 93]}, {"key": "to-determine", "type": "clause", "offset": [125, 137]}, {"key": "another-drug", "type": "definition", "offset": [181, 193]}, {"key": "the-member", "type": "clause", "offset": [194, 204]}], "hash": "987134dbbf21b5350c69047f7d7d0df3", "id": 4}, {"snippet": "means the Department of Urban Roads of the MOT.", "size": 3, "samples": [{"hash": "7p1DZ9L8UxW", "uri": "/contracts/7p1DZ9L8UxW#dur", "label": "Financing Agreement", "score": 26.4688568115, "published": true}, {"hash": "jjGhiotyeVy", "uri": "/contracts/jjGhiotyeVy#dur", "label": "Financing Agreement", "score": 21.0, "published": true}, {"hash": "9aIrqv4z2va", "uri": "/contracts/9aIrqv4z2va#dur", "label": "Global Environment Facility Grant Agreement", "score": 21.0, "published": true}], "snippet_links": [{"key": "department-of", "type": "clause", "offset": [10, 23]}], "hash": "2ef6cef0f373e1628b00468c5030d283", "id": 5}, {"snippet": "means Drug Utilisation Review which is a process of a comprehensive review of medication profile by a pharmacist ;", "size": 2, "samples": [{"hash": "iR6K6qg5Gy2", "uri": "https://pcn.gov.ng/wp-content/uploads/2024/09/Pharmacy-Council-of-Nigeria-Act-2022-publication.pdf", "label": "Notice", "score": 21.3827400208, "published": false}, {"hash": "leCmdGhHPgS", "uri": "https://placng.org/i/wp-content/uploads/2022/10/Pharmacy-Council-of-Nigeria-Establishment-Act-2022.pdf", "label": "Notice", "score": 21.30311203, "published": false}], "snippet_links": [{"key": "review-of", "type": "clause", "offset": [68, 77]}, {"key": "medication-profile", "type": "definition", "offset": [78, 96]}], "hash": "a88f6cc3f8b4a4b0239106e146f8ef34", "id": 6}, {"snippet": "means concurrent Drug Utilization Review.", "size": 2, "samples": [{"hash": "ca3kPoo7xYS", "uri": "/contracts/ca3kPoo7xYS#dur", "label": "Prescription Drug Discount Card Agreement (Free for All, Inc)", "score": 21.0711841583, "published": true}, {"hash": "6eAfdAB0zdk", "uri": "/contracts/6eAfdAB0zdk#dur", "label": "Prescription Drug Discount Card Agreement (Free for All, Inc)", "score": 21.0082130432, "published": true}], "snippet_links": [{"key": "concurrent-drug-utilization-review", "type": "clause", "offset": [6, 40]}], "hash": "42baa9f871a3a21b6e3373bbe7296db3", "id": 7}, {"snippet": "<integer>, // duration (in minutes) over which the temperature was high \"time\": <integer>, // UTC time in seconds, time at which the first high alarm was triggered \"aTmp\": <double>, // (optional) ambient temperature in degrees Celsius \"cnf\": <boolean>, // (optional) false: alarm unconfirmed, true: alarm confirmed \u201ccnfms\u201d: \u201c<string>\u201d // (optional) message associated with the confirmation, if any },", "size": 2, "samples": [{"hash": "fz3xT7uqOie", "uri": "/contracts/fz3xT7uqOie#dur", "label": "Invitation to Bid", "score": 30.1356105804, "published": true}, {"hash": "87oNrkSR9lt", "uri": "/contracts/87oNrkSR9lt#dur", "label": "Invitation to Bid", "score": 29.7578544617, "published": true}], "snippet_links": [{"key": "time-at-which", "type": "clause", "offset": [115, 128]}, {"key": "ambient-temperature", "type": "definition", "offset": [196, 215]}, {"key": "associated-with", "type": "definition", "offset": [357, 372]}], "hash": "a2ddca7ecc66fb25e3d5d22d1819ba55", "id": 8}, {"snippet": "means drug utilization review.", "size": 1, "samples": [{"hash": "aUJkYQ9RWjp", "uri": "/contracts/aUJkYQ9RWjp#dur", "label": "Pharmacy Benefit Services Agreement (Advance Paradigm Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "drug-utilization-review", "type": "definition", "offset": [6, 29]}], "hash": "5412cd02fc1f3eb6b7dcdf18812501b3", "id": 9}, {"snippet": "means Drug Utilization Review which refers to a process designed to ensure that prescriptions are appropriate, medically necessary and not likely to result in adverse medical outcomes.", "size": 1, "samples": [{"hash": "duAA8g58WoT", "uri": "https://www.michigan.gov/documents/buymichiganfirst/Pharmacy_Benefits_Services_RFP_071I9200185_-_PBM_At1_280459_7.doc", "label": "www.michigan.gov", "score": 10.5373029709, "published": false}], "snippet_links": [{"key": "drug-utilization-review", "type": "definition", "offset": [6, 29]}, {"key": "to-ensure", "type": "clause", "offset": [65, 74]}, {"key": "medically-necessary", "type": "definition", "offset": [111, 130]}], "hash": "ec9fc3b1d18161f9e08d8e4b5e79e18a", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMZHVyIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means the process whereby the therapeutic effects and cost effectiveness of various drug therapies are reviewed, monitored and acted upon consistent with the Benefit Plan. DUR can be prospective, concurrent or retrospective.", "size": 36, "title": "DUR", "id": "dur", "examples": ["The Contractor shall provide the <strong>DUR</strong> Board statistics at the <strong>DUR</strong> Board\u2019s monthly meetings.", "In accordance with IC \u2587\u2587-\u2587\u2587-\u2587\u2587-\u2587\u2587, the <strong>DUR</strong> Board shall review the prescription drug programs of the Contractor at least one (1) time per year.", "The Contractor shall provide OMPP with the information necessary for the <strong>DUR</strong> Board to conduct this review in the timeframe and format specified by OMPP.", "The format of this report will be agreed upon by the Contractor, the Office and the <strong>DUR</strong> Board.", "In addition, the Contractor shall comply with any additional reporting requests required for submission to the <strong>DUR</strong> Board.", "The Contractor, implementing a unified PDL, shall implement prior authorization approved for all plans, by the <strong>DUR</strong> Board.", "The Contractor shall supply, on a quarterly basis, a report to the Office and the <strong>DUR</strong> Board of the number of member days of missed therapy due to prior authorization.", "These criteria and edits must be reviewed and approved by the <strong>DUR</strong> Board prior to implementation.", "The Contractor shall participate in the development and recommendation of PA criteria brought before the <strong>DUR</strong> Board.", "The Contractor shall also participate in meetings and proceedings with external entities as directed by FSSA, including but not limited to, the <strong>DUR</strong> Board, MHQAC, Medicaid Advisory Committee, Therapeutics Committee, Indiana Psychotropic Medication Advisory Committee and legislative hearings."], "related": [["medical-management-technique", "Medical management technique", "Medical management technique"], ["stillbirth", "Stillbirth", "Stillbirth"], ["medical-cannabis-card", "Medical cannabis card", "Medical cannabis card"], ["medical-cannabis-pharmacy", "Medical cannabis pharmacy", "Medical cannabis pharmacy"], ["preschooler", "Preschooler", "Preschooler"]], "related_snippets": [], "updated": "2025-07-24T04:27:51+00:00"}, "json": true, "cursor": ""}}